Onchocerciasis Network Meeting

3-4 October 2018 
Kampala, Uganda

The Onchocerciasis Research Network Meeting took place during the 11th DNDi Partners’ Meeting.

 

Opening

Date:Wednesday, 3 October 2018
Time:
 08:00-8:15
Venue: Room Royal, Speke Resort and Conference Centre

Welcome & meeting objectives

Sabine Specht, Head of Filariasis Clinical Programme, DNDi, Switzerland

Belén Pedrique, Medical Manager, Filariasis Programme, DNDi, Switzerland

 

Sessions

Onchocerciasis in Africa

Time: 08:15-10:45

Progress of onchocerciasis programs in Africa and the challenges to reach elimination
Tony Ukety, Former Medical Officer in charge of river blindness, WHO Department of NTDs, & Consultant Ophthalmologist & NTD Expert, DRC

Country-specific situation of clinical trials and research – Ghana
Benjamin Marfo, Deputy NTD Program Manager, Ghana

Cameroon: Country progress towards elimination and research update
Benjamin Didier Biholong, Coordonnateur du Programme National de Lutte contre l’Onchocercose (PNLO), Cameroon

DRC: Country progress towards elimination and research update
Naomi Pichouna Awaca, Director of PNLO and focal point of MTN in DR, DRC

Uganda: Country progress towards elimination
David W. Oguttu, Programme Manager, Onchocerciasis. NTD Control Programme. Vector Control Division-Ministry of Health. Uganda

Uganda: New vector control methods under research
Thomson Luroni Lakwo, Senior Entomologist. Former Programme Manager-Onchocerciasis. Vector Control Division-Ministry of Health. Uganda

Uganda: Onchocerciasis associated epilepsy and nodding syndrome research
Richard Idro, Head of Paediatric Neurology program at Makerere University College of health sciences/Mulago Hospital. Kampala Uganda

 

Platforms and Research Centres: Sharing experiences

Time: 11:00-14:30

KCCR Kumasi, Ghana and TAKeOFF platform (Tackling the Obstacle to Fight Filariasis and Podoconiosis)
Alexander Debrah, Associate Professor of Parasitology and Global Health, Kwame Nkrumah University of Science and Technology, & Coordinator TAKeOFF Consortium, Ghana

UHAS
Nick Opoku, Clinical trial PI, Ghana

CRMT Rethy
Tony Ukety, Former Medical Officer in charge of river blindness, WHO Department of NTDs, & Consultant Ophthalmologist & NTD Expert, DRC

REFODTE, Buea Cameroon
Samuel Wanji, Professor of Public Health Parasitology & Entomology, Head of Department of Microbiology & Parasitology. University of Buea, Cameroon

CRFilMT, Yaounde Cameroon and CANTAM
Joseph Kamgno, Director of the Centre for Research on Filariasis and other Tropical Diseases (CRFilMT), Cameroon

NSETHIO project
Bob Colebunders, NSETHIO project, Global Health Institute, Belgium

HAT platform experience
Florent Mbo, HAT Platform Coordinator, DNDi DRC

 

Current research landscape in onchocerciasis – Part 1

Time: 14:30-15:30

Clinical research in onchocerciasis – DOLF
Peter Fischer, Associate Professor of Medicine, Washington University School of Medicine Infectious Diseases Division Molecular Helminthology & DOLF Project, USA

Clinical research in onchocerciasis – Bonn University
Ute Klarmann-Schulz, Institute for Medical Microbiology, Immunology and Parasitology (IMMIP), University Hospital Bonn. Germany

Clinical research in onchocerciasis – TNT project and other studies
Joseph Kamgno, Director of the Centre for Research on Filariasis and other Tropical Diseases (CRFilMT), Cameroon
Michel Bousinesq, Parasitologist, lnstitut de Recherche pour le Développement (IRD), France

 

Current research landscape in onchocerciasis – Part 2

Date: Thursday, 4 October 2018
Time:
 8:00-9:00

Alternative Strategies for the Acceleration of Elimination of Onchocerciasis in Cameroon
Samuel Wanji, Professor of Public Health Parasitology & Entomology, Head of Department of Microbiology & Parasitology. University of Buea, Cameroon

Moxidectin studies: community study comparing moxidectin and ivermectin in Ituri, DRC
Annette Kuesel, Scientist, WHO, Switzerland
Michel Mandro, Provincial Division of Health of Ituri, DRC
Tony Ukety, Former Medical Officer in charge of river blindness, WHO Department of NTDs, & Consultant Ophthalmologist & NTD Expert, DRC
Mark Sullivan, Founder and Managing Director of Medicines Development, Australia

Moxidectin pediatric study in Ghana
Annette Kuesel, Scientist, WHO, Switzerland
Nick Opoku, Clinical trial PI, Ghana

Onchocerciasis Associated Epilepsy clinical trials

Bob Colebunders, NSETHIO project, Global Health Institute, Belgium

 

Onchocerciasis: What are the patients’ needs?

Time: 9:00-9:30

Unmet Medical Need of onchocerciasis patients and DNDi landscape – Target Product Profile for onchocerciasis case management
Sabine Specht, Head of Filariasis Clinical Programme, DNDi, Switzerland

 

Registration & access of new drugs in Africa

Time: 9:45-10:15

Moxidectin experience for FDA registration and options for registration in Africa
Annette Kuesel, Scientist, WHO, Switzerland
Mark Sullivan, Founder and Managing Director of Medicines Development, Australia

Access strategies for new treatments
Belén Pedrique, Medical Manager, Filariasis Programme, DNDi, Switzerland